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Epidemiological and experimental studies support the idea that helminth infections can induce a protec-
tive effect against the development of autoimmune and allergic diseases. In this study we characterized
the immune response induced by Strongyloides venezuelensis infection in C57BL/6 mice and then evalu-
ated the effect of a previous contact with this helminth in the outcome of type 1 diabetes. Animals were
initially infected with 2000 L3 larvae from S. venezuelensis and euthanized 22 days later. An acute phase,
identiﬁed by a high amount of eggs per gram of feces, was established between days 7 and 9 post-infec-
tion. Recovery from infection was associated with a Th2 polarized response characterized by a signiﬁcant
level of serum IgG1 speciﬁc antibodies and also a signiﬁcant production of IL-5 and IL-10 by spleen cells
stimulated with S. venezuelensis soluble antigen. Immunization with soluble S. venezuelensis antigen asso-
ciated with complete Freund’s adjuvant followed by infection with S. venezuelensis protected mice from
diabetes development induced by streptozotocin. Protection was characterized by a higher body weight
gain, lower glycemic levels, much less severe insulitis and preserved insulin production. Together, these
results indicate that S. venezuelensis contributed to protect C57BL/6 mice against experimental diabetes
induced by streptozotocin.
 2013 Elsevier Inc. Open access under the Elsevier OA license.Microbiologia e Imunologia,
lista (UNESP), Botucatu, São
lo 18618-000, Brazil. Fax: +55
sevier OA license.1. Introduction
Type 1 diabetes (T1D) is a chronic autoimmune disorder associ-
ated, in genetically susceptible individuals, with generation and
activation of autoreactive T cells that recognize pancreatic b-cell
autoantigens. Self-reactive CD4+ and CD8+ T lymphocytes inﬁltrate
184 R.S. Peres et al. / Experimental Parasitology 134 (2013) 183–189the pancreas and selectively destroy the insulin producing b-cells
in the islets (Chentouﬁ et al., 2008). T1D has clearly increased in
prevalence over the last several years in developed countries
(Shapira et al., 2010). Mice and rats have been widely used as
experimental models to investigate the contribution of helminths
and other environmental agents to regulate the immune system
during allergy and autoimmune diseases. Epidemiological
evidences strongly suggest that improved standards of living are
associated with an increased incidence of immune system-medi-
ated diseases as allergies and autoimmune pathologies. A theory
known as the ‘‘hygiene hypothesis’’ suggests that improved health
standards through sanitation and vaccination may in part be
responsible for the apparent increase in immune-mediated dis-
eases due to decreased microbiological and parasitic infections in
humans, particularly in children (Whary and Fox, 2004). Thus, par-
asitic infections might somehow shape the immune system to
avoid exaggerated inﬂammatory responses (Cooke et al., 2004; Ro-
mani, 2008; Vercelli, 2006). Epidemiological and experimental
studies have supported the idea that helminth infections can
induce a protective effect against the development of both autoim-
mune and allergic diseases (Zaccone et al., 2008).
Species of Strongyloides are important intestinal parasites of hu-
mans and domestic animals (Grove, 1996; Júnior et al., 2006). S.
venezuelensis is a rodent parasite, usually found in rats and is very
useful as a model to study nematode infections (Marra et al., 2010;
Maruyama et al., 2006). Infective larvae of S. venezuelensis pene-
trate into the skin and migrate to the lungs where they achieve
the fourth stage. Then, these larvae reach the small intestine where
they ﬁnally become adult parasites (Tindall and Wilson, 1988). Our
previous experience with this parasite indicated that it was able, as
many other nematodes, to induce a strong Th2 kind of response in
Lewis rats (Chiuso-Minicucci et al., 2010). Streptozotocin (STZ) is a
nitrosourea antineoplasic agent that exhibits direct pancreatic b-
cell cytotoxicity (Rerup, 1970). This substance has been widely
used to induce two distinct experimental forms of diabetes. An
inﬂammatory form of diabetes with clinical and immunohistolog-
ical features similar to those found in human type 1 diabetes, can
be induced by injection of multiple low doses of STZ in susceptible
strains of mice (Kolb, 1987; Like and Rossini, 1976).
The purpose of this study was to determine if S. venezuelensis
infection was able to induce a strong Th2 response in C57BL/6 mice
as we observed in Lewis rats. In addition, as accentuated Th2 pro-
ﬁles have been associated with immunomodulatory ability, we
also tested the effect of this infection on the outcome of experi-
mental autoimmune diabetes.
2. Materials and methods
2.1. Animals
Male C57BL/6 mice were purchased from CEMIB (UNICAMP,
Campinas, SP, Brazil). Mice received sterilized food and water ad
libitum and were manipulated in compliance with the ethical
guidelines adopted by the Brazilian College of Animal Experimen-
tation, being the experimental protocol approved by the local Eth-
ics Committee (protocol 84/08).
2.2. General experimental protocol
Mice were initially infected with S. venezuelensis to determine
the kinetics of the infection. They were euthanized 22 days later
to characterize the immune response. The effect of a previous con-
tact with this helminth on the development of experimental diabe-
tes was then evaluated. This contact was established by
immunization with soluble S. venezuelensis antigens followed by
infection with this worm. Diabetes was induced seven days laterby giving STZ during 5 consecutive days by intraperitoneal route.
Twenty-one days after last STZ injection, animals were euthanized
and diabetes intensity was quantiﬁed by increase in body weight,
glycemic levels, insulitis score and in situ insulin production.
2.3. Immunization and infection with S. venezuelensis
The S. venezuelensis strain was isolated from wild rats in 1980.
The strain was then maintained in Wistar rats, routinely infected
in the Parasitology Laboratory of the Univ. Estadual Paulista (UN-
ESP). For the experimental infections, infective third-stage larvae
(L3) of S. venezuelensis were obtained from fecal cultures using
sterilized horse manure as substrate. The cultures were incubated
at 25 C for 72 h and the infective larvae were collected and con-
centrated by using a Baermann apparatus. Recovered larvae were
washed in phosphate-buffered saline (PBS) and their number was
estimated under stereo-microscopy. These L3 were used for both,
soluble antigen preparation and infection. To obtain soluble anti-
gen as previously described (Fernandes et al., 2008), larvae were
resuspended in RPMI medium containing a protease inhibitor
cocktail (Roche Applied Science, Mannnheim, Baden-Wurttemberg,
Germany) and disrupted by vortexing with glass beads (ﬁve cycles
of 1 min each) followed by sonication (10 cycles of 1 min) with a
cell sonic disrupter (Vibra Cell Ultrasonic Processor VCX-400). After
removing the insoluble particles by centrifuging the larvae homog-
enate, the recovered supernatant was ﬁltered through a 0.22 lm
membrane (Millipore) and aliquots were stored at 80 C. The pro-
tein concentration was determined by bicinchoninic acid assay
(Bicinchoninic Acid Kit for protein determination-Sigma, St. Louis,
MO, USA). This antigen was used to estimate antibody levels, to
stimulate spleen cell cultures in vitro and also to immunize the ani-
mals. Mice were immunized with 50 lg of L3 antigen in complete
Freund’s adjuvant (CFA) and one week later they were subcutane-
ously infected at the abdominal region with 2000 L3 larvae.
2.4. Fecal egg count
Infection intensity was determined by counting the number of
eggs per gram of feces (EPG) by a modiﬁed Cornell McMaster
method (Gordon and Whitlock, 1939). Fecal samples were daily
collected until 22 days after infection. Infected animals were allo-
cated in a box and their feces were collected three hours later to
determine the number of eggs.
2.5. Parasite-speciﬁc antibodies
Serum parasite-speciﬁc IgG1 and IgG2a were estimated by ELI-
SA. Brieﬂy, plates (Nunc, Life Tech. Inc., USA) were coated with
100 lg/mL of L3 antigen in coating solution (Na2CO3/NaHCO3, pH
9.6), at 4 C, overnight. Non-speciﬁc protein binding was blocked
by incubation with 200 ll of 0.05% tween 20, 10% fetal calf serum
(FCS) in PBS for 1 h at 37 C. Subsequently, plates were incubated
with serum diluted 1:10 during 1 h at 37 C. For the detection of
speciﬁc IgG1 and IgG2a subclasses, the plates were incubated with
biotinylated rat antimouse antibodies speciﬁc for each isotype
(PharMingen, BD Biosciences, USA) for 1 h at 37 C. Plates were
then incubated for 30 min at room temperature with Strept AB
(kit from Dako, Carpinteria), and revealed by adding H2O2 and o-
phenylenediamine (Sigma, USA). Color development was stopped
with H2SO4 and optical density was measured at 492 nm.
2.6. Cytokine production by spleen cells
Spleen cells were collected and adjusted to 5  106 cells/mL.
They were then cultured in RPMI medium supplemented with
10% FCS, 2 mM L-glutamine and 40 mg/L of gentamicin, in the
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10 lg/mL of concanavalin A (ConA, Sigma, St. Louis, MO, USA).
Cytokine levels were evaluated 72 h later by ELISA, in culture
supernatants, according to manufacturer instructions (BD
Biosciences, San Jose, California, USA). Sensitivity of ELISA for
IFN-c, IL-5 and IL-10 were 16; 8 and 16 pg/mL, respectively.
2.7. Analysis of weight gain and glycemic levels in STZ-induced
diabetes
In order to induce diabetes, male C57BL/6 mice were given
daily intraperitoneal injections of STZ diluted in citrate buffer,
(40 mg/kg, Sigma–Aldrich, St. Louis, MO) for ﬁve consecutive days.
Body weight was evaluated twice a week. Non-fasted serum
glucose concentration was measured using Prestige LX Smart
System Test-strips (Home Diagnostic, Inc., Fort Lauderdale, FL)
once a week, beginning 7 days after the last STZ dose. The animals
were considered diabetic when glucose blood level was higher
than 200 mg/dL during 2 consecutive weeks.0 
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Fig. 1. Characterization of the immune response during the recovery phase of S. venezuel
pool (a). Speciﬁc serum IgG1 and IgG2a (b), speciﬁc cytokine induction: IL-5 (c); IL-10
evaluated by ELISA in spleen culture supernatants. Data represents the mean ± SD from2.8. Histopathological analysis
Three weeks after the last STZ injection, the pancreata were re-
moved and ﬁxed in buffered formalin 10% (phosphate buffer
pH = 7.2) for 24–48 h. The organs were conserved in alcohol 70%
until histological processing and parafﬁn inclusion. Five microme-
ter sections were cut and stained with hematoxylin and eosin (HE).
Inﬂammatory inﬁltrates were quantitatively evaluated using a
computer-assisted image system based on a Nikon Microphot-
FXA optical microscope connected via a Sony Exwave HAD video
camera to a computer. Total section area of each pancreas was
measured to avoid any inter-animal variance. Islets and inﬂamma-
tion areas were measured individually (Kauri et al., 2007) using the
KS300 software (Carl-Zeiss, AG, Germany). The islet’s area showing
mononuclear cell inﬁltrate was then converted into relative values
(%) according to the formula: mononuclear inﬁltrate area
(lm2)  100/islet’s area (lm2). The results were further catego-
rized into a speciﬁc score: 0 = intact islet; 1 = peri-insulitis;
2 = moderate insulitis (<50% of the islet inﬁltrated) and 3 = severe0 
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creas were analyzed in non-consecutive sections.
2.9. Insulin detection
To evaluate the islet’s insulin content, pancreas slides were
initially treated with 0.01 M citrate buffer (pH 6.0) and heated
twice, 5 min each time, in a microwave oven. Slides were then
incubated with 3% H2O2 in PBS for 10 min and non-fat milk for
60 min, to block endogenous peroxidase and endogenous biotin,
respectively. Insulin content was revealed by incubation with*
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Fig. 2. Clinical and histopathological alterations triggered by STZ in C57BL/6 mice previou
a week and the percentage of weight variation was determined based on day 0 and d
determined three weeks after last STZ dose (c). Results represent the average among 6polyclonal guinea pig anti-insulin antibody (dilution 1:500, Dako
Glostrup, Denmark) overnight and then with rabbit anti-guinea
pig IgG coupled with peroxidase (Dako, Glostrup, Denmark).
Chromogen color development was accomplished with 3,30-
diaminobenzidine tetrahydrochloride (Sigma). The slides were
counterstained with Harris’s hematoxylin and morphometric
analysis was performed with a computer-assisted image system,
as described above. The islet’s insulin content was established by
calculating the area of immunopositive insulin relative to the
islet’s area, according to the formula: insulin positive area
(lm2)  100/islet’s area (lm2).*
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Data were expressed as mean ± SD. Comparisons between
groups were made by Student’s t test or one way ANOVA with post
hoc Holm-Sidak test for parameters with normal distribution, and
by Mann–Whitney U test or Kruskal–Wallis test for parameters
with non-normal distribution. Signiﬁcance level was p < 0.05.
Statistical analysis was accomplished with SigmaStat for Windows
v 3.5 (Systat Software Inc).
3. Results
3.1. Recovery from S. venezuelensis infection is associated with a Th2
polarized response
As can be observed in Fig. 1a, C57BL/6 mice presented an acute
infection characterized by a high amount of EPG between days 7
and 9 post infection. From the 12th day on, no more eggs were0 
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Fig. 3. In situ production of insulin in mice protected against diabetes by contact with S. v
with CFA and then infected with S. venezuelensis. Three weeks after infection, diabetes w
immunohistochemistry. Normal control (a), STZ (b) and AgSv+inf+STZ (c).detected. Even though antibody levels were low, there was a signif-
icant production of IgG1, but not IgG2a, during the recovery phase
(Fig. 1b). IL-5, IL-10 and IFN-c production induced by speciﬁc anti-
gen stimulation (Fig. 1c, e and g, respectively) were signiﬁcantly
elevated during this phase. A signiﬁcant increase was also ob-
served in the production of IL-5 and IL-10 (Fig. 1d and f, respec-
tively) by spleen cell cultures stimulated with ConA. IFN-c levels
induced by ConA were similar in the control and infected groups
(Fig. 1h).
3.2. S. venezuelensis contributed to protect against diabetes
Immunization of C57BL/6 mice with soluble antigens from S.
venezuelensis associated with CFA, followed one week later by
infection with 2000 L3 from this worm, determined a clear protec-
tion from diabetes development induced by STZ. As expected, STZ
inoculation clearly avoided normal body weight increase, i.e.,
whereas the control group gained 15.7% of their original weight,STZ CFA 
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AgSv+STZ also gained signiﬁcantly less weight during the experi-
mental period, 0.4% and 4.6%, respectively. On the other hand,
the group that was immunized and later infected with S. venezuel-
ensis before STZ inoculation signiﬁcantly preserved this weight
gain (Fig. 2a).
The clearest differences in glycemic levels were observed
14 days after STZ inoculation. As showed in Fig. 2b, among the
STZ groups, only the one previously immunized and then infected
with S. venezuelensis (AgSv+inf+STZ) presented glycemic levels be-
low 200 mg/dL. This value was statistically different from the value
found in the STZ group. Even though a similar proﬁle was observed
at the 21st day after diabetes induction, no statistical difference
was detected among the groups.
The three procedures protected against insulitis. However,
immunization followed by infection with S. venezuelensis deter-
mined the most signiﬁcant effect. In this case, 70% of the islets re-
mained at score zero, i.e., they presented no inﬂammation. In mice
injected with CFA associated or not with S. venezuelensis antigens
the percentage of islets with score zero was around 40%.
Otherwise, only 10% of the islets remained preserved in the STZ
control group (Fig. 2c).
3.3. Insulin detection
As expected and showed in Fig. 3a, a widespread immunohisto-
chemical detection of insulin was observed in normal pancreas. In
contrast, staining for insulin was very discrete in pancreas obtained
from mice submitted to diabetes development by STZ inoculation
(Fig. 3b). Previous contact with CFA alone (CFA+STZ) or associated
with S. venezuelensis antigens (AgSv+STZ and AgSv+inf+STZ groups)
highly preserved the ability to produce insulin. Even though insulin
staining seemed more preserved in the AgSv+inf+STZ group, a
quantitative analysis indicated no statistical difference in compar-
ison to the CFA+STZ group. Staining for insulin in AgSv+inf+STZ
group is illustrated in Fig. 3c.
3.4. Protection associated with S. venezuelensis was linked to higher
IL-5 and IL-10 production
Production of IL-5 (Fig. 4a) and IL-10 (Fig. 4c) induced by in vitro
stimulation of spleen cells with soluble S. venezuelensis antigen
was higher in the two groups that had a previous contact with
worm antigens by immunization followed or not by infection.
Comparison between AgSv+STZ and AgSv+inf+STZ groups indi-
cated that IL-5, but not IL-10 levels, were statistically higher in
AgSv+inf+STZ group. In spleen cell cultures polyclonally stimulated
with ConA, there was a signiﬁcant production of both cytokines
only in the AgSv+inf+STZ group. IL-5 and IL-10 production can be
observed in Fig. 4b and d, respectively.4. Discussion
Helminths are a highly diverse group of organisms with distinct
morphologies and life cycle stages that are able to cause a multi-
plicity of diseases in humans and animals (Schiefke et al., 2006).
Despite many differences, they share the potential to trigger pro-
found regulatory effects over the immune system (Cooke et al.,
1999; Flohr et al., 2009). In this investigation we evaluated the
ability of S. venezuelensis to modulate the development of experi-
mental diabetes induced by multiple streptozotocin (STZ) doses
in C57BL/6 mice. Male C57BL/6 mice were initially infected with
2000 L3 from S. venezuelensis by subcutaneous route being the
kinetics of the infection determined by counting the number of
eggs per gram of feces (EPG). This analysis indicated the presenceof an acute phase between days 7 and 9 after injection, followed
by a recovery phase whose immunological status was character-
ized 22 days after infection. Even though there was an speciﬁc
induction of IFN-c during this phase, elevated speciﬁc induction
of IL-5 and IL-10 and also signiﬁcant IgG1 production characterized
a predominant Th2 proﬁle during this period. This proﬁle was also
reinforced by elevated production of IL-5 and IL-10, but not IFN-c,
after ConA stimulation. These ﬁndings demonstrated that strongy-
loidiasis in C57BL/6 mice is similar to other rodent helminthiasis
(Baek et al., 2003; Chiuso-Minicucci et al., 2010; Kimura et al.,
1999) and also that it establishes a Th2 environment as described
for other worms (Chiuso-Minicucci et al., 2010; Machado et al.,
2005; Machado et al., 2007).
To evaluate the effect of a previous contact with S. venezuelensis
on diabetes, mice were immunized or infected with this worm be-
fore STZ disease induction. Previous infection by itself induced a
very discrete protective effect (not shown). However, the stronger
stimulation achieved by immunization with soluble S. venezuelen-
sis antigens followed by infection with this worm, triggered a sig-
niﬁcant protective effect. In this case, the animals gained more
weight, presented glucose levels below the ones found in STZ con-
trol group and also displayed a striking preservation of the pancre-
atic islets. Seventy percent of the islets were completely preserved
in previously immunized/infected groups whereas the STZ control
group presented only 10% of islets with zero score. In addition to
this structural preservation, this experimental group also pre-
sented the highest percentage of islets area producing insulin.
Comparing to the control group, whose total insulin producing area
was considered 100%, the percentages of areas able to produce this
hormone were 14%, 66.7% and 74.3% in STZ, CFA+STZ and
AgSv+inf+STZ groups, respectively. Similar protective ﬁndings
mediated by other helminths were also reported in this model.
For example, El-Wakil et al., 2002, demonstrated that Schistosoma
mansoni egg deposition, which leads to a shift from a Th1 to a
Th2 proﬁle, suppressed diabetes development. Also, very recently,
Espinoza-Jiménez et al., 2010 demonstrated that Taenia crassiceps
infection attenuated this disease, determining a lower diabetes
incidence, a much smaller degree of insulitis and also preserved
pancreatic insulin production. An expressive level of protection
was achieved in our investigation when immunization with solu-
ble S. venezuelensis antigens was followed by infection with this
helminth. A possible explanation for this requirement could be
linked to the fact that S. venezuelensis is an acute parasitic disease,
usually controlled by the host immune response (Fernandes et al.,
2008) whereas T. crassiceps and S. mansoni determine chronic types
of infections (Machado-Silva et al., 2010; Morales-Montor et al.,
2001).
It’s important to highlight, however, that mice immunized with
soluble S. venezuelensis antigen emulsiﬁed with CFA and their
respective control, i.e., mice solely injected with CFA, also present
a smaller but signiﬁcant level of protection. It is possible, therefore,
that the high protection triggered by immunization followed by S.
venezuelensis infection was initiated by the stimulus derived from
S. venezuelensis soluble antigens or by the CFA itself. Even though
mycobacteria and helminths have been both indicated as possible
‘‘old friends’’ of humans beings, able to regulate autoimmunity,
their possible association determining a stronger immunoregula-
tory effect has not being investigated. Further experiments will
be necessary to unravel the real contribution of mycobacteria pres-
ent in CFA to this protective effect.
Theoretically, we could attribute this enhanced protective effect
observed in the AgSv+inf+STZ group to the concurrence of distinct
mechanisms. On one hand, it is well known that diverse sources of
mycobacterial antigens as CFA, BCG and Mycobacterium avium are
able to prevent experimental diabetes (Brás and Aguas, 1996;
Gao et al., 2010; Qin and Singh, 1997; Ryu et al., 2001). A plethora
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nomodulation, including direct or indirect induction of regulatory
cells (Manirarora et al., 2008; McInerney et al., 1991), deviation
of Th1 response to non-deleterious Th2 proﬁle (Qin et al., 1998)
and up-regulation of TNF-a expression that leads to apoptosis of
diabetogenic T cells (Qin et al., 2004). On the other hand, infections
with helminths can also be beneﬁcial to the host as they are able to
suppress allergic and autoimmune responses (Wilson and Maizels,
2004). Recent reports indicated that the ability of helminths to de-
crease type 1 diabetes incidence is related to increased activity of
Th2 and Treg cells (Hübner et al., 2009; Zaccone et al., 2009).
Quantiﬁcation of some cytokines in the supernatants of spleen
cell cultures stimulated with speciﬁc antigen or ConA partially ex-
plained the contribution of S. venezuelensis to this protection. In
cultures stimulated with speciﬁc soluble antigen, the AgSv+inf+STZ
group produced higher levels of IL-5 and IL-10 in comparison to the
group that was only immunized. The same cytokine proﬁle was ob-
served in cultures stimulated with ConA. These ﬁndings suggested
that both IL-5 and IL-10 could contribute to this protection. Proto-
cols that increase the level of these cytokines have been associated
with protection from antiretinal autoimmunity (Cortes et al.,
2008), autoimmune diabetes (Perone et al., 2009) and arthritis
(van Duivenvoorde et al., 2007).
5. Conclusion
Together these results demonstrate that S. venezuelensis was
able to increase the ability of CFA to protect against experimental
diabetes. These ﬁndings suggest that a deeper investigation is
mandatory to highlight the meaning of the emerging hypothesis
that ‘‘old friends’’ could act in concert to regulate autoimmunity.
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